Effect of Cold Atmospheric Plasma on Malassezia Folliculitis

• Status: Not yet recruiting
• Trial end date: 2023-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The cold atmospheric plasma may provide a new and effective method for the treatment of Malassezia folliculitis. The investigators conduct this randomized controlled trial to evaluate the effectiveness and safety of cold atmospheric plasma on Malassezia folliculitis. Participants entered this double-blind placebo-controlled trial will randomly assign to treatment with either cold atmospheric plasma or topical antifungal drugs. The differences of treatment effects of the two groups will be observed and compared.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The Second Hospital of Anhui Medical University
• Collaborator: Hefei CAS Ion Medical and Technical Devices Co.,Ltd
• Treatments: Ketoconazole

Criteria

Inclusion Criteria:

• Patients are clinical presentation of Malassezia folliculitis in seborrheic areas.

• The diagnoses are mycologically verified by experienced laboratory technicians.

• Participants must be informed of the investigational nature of this study and be willing to provide written informed consent.

Exclusion Criteria:

• Combined with other serious systemic diseases.

• History of topical corticosteroids within 2 weeks or history of systemic corticosteroids within 1 month.

• History of immunosuppressive drugs within 1 month.

• History of topical antifungal medication within 2 weeks or systemic antifungal medication within 3 months.

• Pregnant and lactating women.